Head of the Group

Prof. Dr.-Ing. Udo Reichl
Prof. Dr.-Ing. Udo Reichl
Phone: +49 391 6110 201
Fax: +49 391 6110 203
Room: N0.19

Contact Person

Annegret Frauendienst
Phone:+49 391 6110-200Fax:+49 391 6110-203

Group Page

Publications

Publications BPE group

Talk (251)

  1. 551.
    Talk
    Reichl, U.: Theoretical and Experimental Characterization of Influenza Virus Replication in Cell Cultures. Meeting Helmholtz-Zentrum, Braunschweig, Germany (2007)
  2. 552.
    Talk
    Reichl, U.: Theoretical and Experimental Characterization of Influenza Virus Replication in Cell Cultures. DECHEMA-Arbeitsausschuss Biotechnologie, Frankfurt/M., Germany (2007)
  3. 553.
    Talk
    Reichl, U.: Mathematical Modeling of Mammalian Cell Cultures - Cell Growth and Product Synthesis. MPG-CNRS Treffen, Paris, France (2007)
  4. 554.
    Talk
    Reichl, U.: MDCK cell derived influenza vaccines - aspects of up- and downstream processing. Meeting Merck & Co., Inc., USA (2007)
  5. 555.
    Talk
    Reichl, U.: Mathematical Modeling of Mammalian Cell Cultures: From Cell Populations to Individual Cells. Workshop "Systems biology", Leipzig, Germany (2007)
  6. 556.
    Talk
    Ritter, J. B.; Genzel, Y.; Reichl, U.: Metabolite Analysis in Mammalian Cells: How to generate reliable data sets? 20th ESACT meeting, Dresden, Germany (2007)
  7. 557.
    Talk
    Schmidt, J. K.; Riedele, C.; Regestein, L.; Geisler, L.; Reichl, U.: A Medically Relevant Three-Species Mixed Culture in a Chemostat: Mathematical Modelling and Experiments to Study Interaction Effects. European BioPerspectives 2007, Cologne, Germany (2007)
  8. 558.
    Talk
    Schwarzer, J.; Rapp, E.; Reichl, U.: N-glycan analysis method for cell culture derived influenza virus hemagglutinin. Joint Meeting 2007, Lille, France (2007)
  9. 559.
    Talk
    Genzel, Y.; Kalbfuss, B.; Ritter, J. B.; Schulze-Horsel, J.; Rapp, E.; Vester, D.; Reichl, U.: Characterization and analytical issues on an influenza A virus production process. Vaccines : Quality control, scale-up and manufacture, Hamburg, Germany (2006)
  10. 560.
    Talk
    Genzel, Y.; Sandig, V.; Jordan, I.: Neue Zellsubstrate und Einfluss von Medien und Prozessführung in der Impfstoffproduktion. 24. DECHEMA-Jahrestagung der Biotechnologen, Wiesbaden, Germany (2006)
  11. 561.
    Talk
    Genzel, Y.; Reichl, U.: Production of vaccines based on animal cell technology. Production of Biopharmaceuticals in Animal Cell Cultures, Rio de Janeiro, Brazil (2006)
  12. 562.
    Talk
    Genzel, Y.; Schulze-Horsel, J.; Reichl, U.: High Cell Density Microcarrier Process in a Wave Bioreactor for the Production of Influenza A Virus. Vaccine Technology, Puerto Vallarta, Mexiko (2006)
  13. 563.
    Talk
    Genzel, Y.; Reichl, U.: Limits and benefits of the interpretation of extracellular metabolite data in mammalian cell culture. 1st Max Planck Workshop on "Metabolomics", Magdeburg, Germany (2006)
  14. 564.
    Talk
    Kalbfuss, B.; Wolff, M. W.; Genzel, Y.; Zimmermann, A.; Morenweiser, R.; Reichl, U.: Chromatography-based purification of influenza A virus for the production of human whole-virion vaccines. ISPPP 2006 : 26th International Symposium on the Separation of Proteins, Peptides and Polynucleotides, Innsbruck, Austria (2006)
  15. 565.
    Talk
    Kalbfuss, B.; Wolff, M. W.; Geisler, L.; Thom, V.; Reichl, U.: Konzentrierung und Aufreinigung von Influenza Viren mittels Ionenaustauscher-Membranen. 24. DECHEMA-Jahrestagung der Biotechnologen, Wiesbaden, Germany (2006)
  16. 566.
    Talk
    Kalbfuss, B.; Gedicke, K.; Seidel-Morgenstern, A.; Reichl, U.: Maximizing productivity in size-exclusion chromatography of influenza virus: A modelling approach. ESBES 6 : 6th European Symposium on Biochemical Engineering Science, Salzburg, Austria (2006)
  17. 567.
    Talk
    Kalbfuss, B.; Wolff, M. W.; Genzel, Y.; Zimmermann, A.; Best, C.; Morenweiser, R.; Reichl, U.: A generic purification scheme for the production of human influenza vaccines derived from serum-free mammalian cell culture. Vaccine Technology, Puerto Vallarta, Mexico (2006)
  18. 568.
    Talk
    Reichl, U.: MDCK Cell Derived Influenza Vaccines: Aspects of Up- and Downstream Processing. Meeting Academy of Science, Sofia, Bulgarien (2006)
  19. 569.
    Talk
    Reichl, U.: Dynamics of Influenza Virus Replication in Mammalian Cell Culture. CCEX Workshop, Vancouver, Canada (2006)
  20. 570.
    Talk
    Reichl, U.: MDCK Cell derived Influenza Vaccines: Aspects of Modeling and Experimental Design in Upstream Processing. Meeting at Sanof Pasteur, Toronto, Canada (2006)
  21. 571.
    Talk
    Reichl, U.: Biological Fundamentals, Models and Technologies for Vaccine Production. Perspectives of Research - Identification and Implementation of Research Topics by Organizations : Ringberg-Symposium Mai 2006, Kreuth, Germany (2006)
  22. 572.
    Talk
    Reichl, U.: Mathematical Models for Mammalian Cell Growth and Virus Replication for an Influenza Vaccine Production Process. Technische Universität Berlin : Meeting, Berlin, Germany (2006)
  23. 573.
    Talk
    Ritter, J. B.; Genzel, Y.; Reichl, U.: Monitoring Energy Metabolism: The Challenge of Intracellular Metabolite Analysis of Mammalian Cells in Culture. 1st Max Planck Workshop on "Metabolomics", Magdeburg, Germany (2006)
  24. 574.
    Talk
    Schulze-Horsel, J.; Bock, A.; Genzel, Y.; Reichl, U.: Mammalian cell culture for influenza vaccine production: physiology during cell growth and virus propagation phase. GVC/DECHEMA-Jahrestagungen 2006 mit 24. DECHEMA-Jahrestagung der Biotechnologen, Wiesbaden, Germany (2006)
  25. 575.
    Talk
    Wahl, A.; Nöh, K.; Wiechert, W.: Metabolic and Isotopic Instationary Experiments: A Simulative Study. Metabolic Engineering VI, Noordwijkerhout, The Netherlands (2006)
  26. 576.
    Talk
    Wahl, S. A.; Nöh, K.; Wiechert, W.: Experiments at Metabolic and Isotopic Instationary State: An Exploratory study. Metabolic Engineering VI : From recDNA Towards Engineering Biological Systems, Noordwijkerhout, Netherlands (2006)
  27. 577.
    Talk
    Wolff, M. W.; Kalbfuss, B.; Opitz, L.; Zimmermann, A.; Lehmann, S.; Reichl, U.: Downstream Process of Influenza Viruses. European BioPharm Scale-Up Congress 2006, Geneva, Switzerland (2006)
  28. 578.
    Talk
    Wolff, M. W.; Kalbfuss, B.; Lehmann, S.; Morenweiser, R.; Opitz, L.; Zimmermann, A.; Reichl, U.: Downstream Processes and Glycan Characterization of MDCK-Cell Derived Influenza Virus. BioProcess Technology - Asia, Singapore (2006)
  29. 579.
    Talk
    Genzel, Y.; Schulze-Horsel, J.; Möhler, L.; Sidorenko, Y.; Reichl, U.: Influenza Vaccines: Challenges in Mammalian Cell Culture Technology. 19th ESACT Meeting, Harrogate, UK (2005)
  30. 580.
    Talk
    Heßeler, J.; Schmidt, J. K.; Reichl, U.; Flockerzi, D.: How to achieve coexistence in the chemostat: a combined mathematical and experimental approach. European Conference on Mathematical and Theoretical Biology (ECMTB), Dresden, Germany (2005)
  31. 581.
    Talk
    Wolff, M.; Kalbfuss, B.; Morenweiser, R.; Zimmermann, A.; Reichl, U.: Chromatography-based Purification of Influenza A Virus for the Production of Human Whole-Virion Vaccines. Viral Vectors and Vaccines Conference, Austin, Texas (2005)
  32. 582.
    Talk
    Wolff, M. W.; Salaklang, J.; Opitz, L.; Schwarzer, J.; Rapp, E.; Kalbfuss, B.; Reichl, U.: Development of a lectin-affinity chromatography step for the downstream processing of influenza virus vaccines. AICHE Annual Meeting 2005, Cincinnati, Ohio, USA (2005)
  33. 583.
    Talk
    Genzel, Y.; König, S.; Reichl, U.: Amino acid analysis in mammalian cell culture based virus vaccine production processes. IICS : 17th annual International Ion Chromatography Symposium, Trier, Germany (2004)
  34. 584.
    Talk
    Rapp, E.; Lubda, D.; Seidel-Morgenstern, A.; Reichl, U.; Tallarek, U.: Sheathless ESI-Interface for Coupling Capillary Separation Techniques to Mass Spectromety. 37. Diskussionstagung der Deutschen Gesellschaft für Massenspektrometrie, Leipzig, Germany (2004)

Poster (318)

  1. 585.
    Poster
    Chuzel, L.; Ganatra, M.B.; Fossa, S.L.; Rapp, E.; Taron, C.: A functional metagenomics workflow for discovery of novel glycoside hydrolases. GlycoBioTec 2019, Berlin, Germany (2019)
  2. 586.
    Poster
    Grote, V.; Cornean, A.; Hoffmann, M.; Thumberger, T.; Wittbrodt, J.; Reichl, U.; Rapp, E.: Embryonic Development in CDG Model Organism: Site-specific Glycoproteomic Analysis of O-Mannosylation in Oryzias Latipes. GlycoBioTec 2019, Berlin, Germany (2019)
  3. 587.
    Poster
    Hanic, M.; McLeod, B.; Shi, S.; Rapp, E.; Hennig, R.; Lauc, G.; Trbojevic-Akmacic, I.: N-glycans sequencing using a novel exoglycosidase arry and xCGE-LIF analysis. GlycoBioTec 2019, Berlin, Germany (2019)
  4. 588.
    Poster
    Hoffmann, M.; Pioch, M.; Pralow, A.; Hennig, R.; Kottler, R.; Reichl, U.; Rapp, E.: The Fine Art of Destruction: A Guide to In-Depth Glycoproteomic Analyses - Exploiting the Diagnostic Potential of Fragment Ions. GlycoBioTec 2019, Berlin, Germany (2019)
  5. 589.
    Poster
    Pralow, A.; Hoffmann, M.; Pioch, M.; Hennig, R.; Nguyen-Khuong, T.; Genzel, Y.; Rapp, E.; Reichl, U.: Comprehensive N-glycosylation analysis of influenza A virus antigens derived from different production cell lines reveal immunogenic glycan epitopes. GlycoBioTec 2019, Berlin, Germany (2019)
  6. 590.
    Poster
    Rossdamm, C.; Konze , S.A.; Oberbeck, A.; Rapp, E.; Gerardy-Schahn, R.; von Itzstein, M.; Buettner, F.F.R.: xCGE-LIF as a novel approach for the analysis of glycoshingolipid-derived glycans. GlycoBioTec 2019, Berlin, Germany (2019)
  7. 591.
    Poster
    Zuniga-Banuelos, F.; Hoffmann, M.; Reichl, U.; Rapp, E.: In-Depth N-Glycoproteomic Analysis of Human Blood Plasma Proteins. GlycoBioTec 2019, Berlin, Germany (2019)
  8. 592.
    Poster
    Benndorf, D.; Heyer, R.; Schallert, K.; Püttker, S.; Kohrs, F.; Theuerl, S.; Schlüter, A.; Reichl, U.: Metaproteomics of biogas plants reveals that biogas producing microbial communities are shaped by syntrophy, competition and phage-host interactions. International Society for Microbial Ecology Conference (ISME), Leipzig Germany (2018)
  9. 593.
    Poster
    Bissinger, T.; Rodrigues Correia Ramos, J.; Ringeisen, J.; Genzel, Y.; Reichl, U.: Dynamics of intracellular metabolite pools in MDCK suspension cells during cell growth and influenza virus infection. Cell Culture Engineering XVI, Tampa, Florida, USA (2018)
  10. 594.
    Poster
    Bissinger, T.; Wu, Y.; Genzel, Y.; Liu, X.; Wen-Song, T.; Reichl, U.: Efficient influenza virus production: a MDCK-based high-cell-density process. Vaccine Technology VII, Mont Tremblant, Canada (2018)
  11. 595.
    Poster
    Coronel, J.; Behrendt, I.; Bürgin, T.; Anderlei, T.; Sandig, V.; Genzel, Y.; Reichl, U.: Orbital shaken bioreactor for influenza A virus production in high cell density cultivations. Vaccine Technology VII, Mont Tremblant, Canada (2018)
  12. 596.
    Poster
    Hoffmann, M.; Bartels, M.F.; Noor, S.I.; Hennig, R.; Pioch, M.; Reichl, U.; Strahl, S.; Rapp, E.: Unravelling the Interplay between Protein O-Mannosylation and N-Glycosylation - A Glycomic and Glycoproteomic Study of Human N-Cadherin. DFG FOR 2509 Meeting, Höchst (Odenwald), Germany (2018)
  13. 597.
    Poster
    Laske, T.; Bachmann, M.; Dostert, M.; Frensing, T.; Karlas, A.; Wirth, D.; Reichl, U.: Modeling reveals changes in key parameters of infuenza A virus replication in engineered cell lines. 11th Annual International Conference on Systems Biology of Human Diseases, Los Angeles, USA (2018)
  14. 598.
    Poster
    Nikolay, A.: CCE: The EB66 (R) Cell line for Yellow Fever Vaccine procustion at high cell concentrations. Cell Culture Engineering XVI, Tampa, Florida, USA (2018)
  15. 599.
    Poster
    Nikolay, A.: Flavivirus production in perfusion processes using the EB66 (R) Cell line. Vaccine Technology VII, Mont Tremblant, Canada (2018)
  16. 600.
    Poster
    Rüdiger, D.; Kupke, S. Y.; Reichl, U.: A multiscale model of influenza A virus replication covering highly different infection conditions in cell cultures. Foundations of Systems Biology in Engineering - 7th FOSBE 2018, Oak Brook, Illinois, USA (2018)
 
loading content
Go to Editor View